Mustafa Özdoğan

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Effect of Iron Deficiency Anemia on the Levels of Hemoglobin A1c in Nondiabetic Patients

Erkan Çoban, Mustafa Özdoğan, Ayşen Timurağaoğlu · Acta Haematologica · 2004 · 303 citations

Medicine, Endocrinology, Hematology +15

The mean platelet volume in patients with obesity

Erkan Çoban, Mustafa Özdoğan, G. Yazicioglu et al. · International Journal of Clinical Practice · 2005 · 292 citations

Medicine, Hematology, Clinical Nutrition +10

The mean platelet volume in subjects with impaired fasting glucose

Erkan Çoban, Feyzi Bostan, Mustafa Özdoğan · Platelets · 2005 · 126 citations

Medicine, Endocrinology, Hematology +13

Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy

Hakan Bozcuk, Gülcan Uslu, Mustafa Samur et al. · Cytokine · 2004 · 105 citations

Medicine, Endocrinology, Oncology +10